87 related articles for article (PubMed ID: 6092897)
21. Melphalan potently substitutes the N-terminal Tyr of D-Ala2-Leu5-enkephalin methyl ester.
Szücs M; Di Gleria K; Medzihradszky K
FEBS Lett; 1985 Jan; 179(1):87-90. PubMed ID: 2981183
[TBL] [Abstract][Full Text] [Related]
22. Direct measurements of in situ interactions of rat brain opioid receptors with the guanine nucleotide-binding protein Go.
Georgoussi Z; Carr C; Milligan G
Mol Pharmacol; 1993 Jul; 44(1):62-9. PubMed ID: 8393523
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of [3H]fentanyl binding to the opiate receptor.
Villiger JW; Ray LJ; Taylor KM
Neuropharmacology; 1983 Apr; 22(4):447-52. PubMed ID: 6304563
[TBL] [Abstract][Full Text] [Related]
24. Anatomical distribution of sodium-dependent [(3)H]naloxone binding sites in rat brain.
Sim-Selley LJ; Xiao R; Childers SR
Synapse; 2000 Mar; 35(4):256-64. PubMed ID: 10657035
[TBL] [Abstract][Full Text] [Related]
25. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
James IF; Goldstein A
Mol Pharmacol; 1984 May; 25(3):337-42. PubMed ID: 6328259
[TBL] [Abstract][Full Text] [Related]
26. [Regulation of opioid receptors by thyroliberin analogues].
Balashov AM; Aliab'eva TN; Panchenko LF
Vopr Med Khim; 2002; 48(5):436-42. PubMed ID: 12498084
[TBL] [Abstract][Full Text] [Related]
27. Arachidonic acid modulation of [3H]naloxone specific binding to rat brain opioid receptors.
Oktem HA; Apaydin S
Neurobiology (Bp); 1998; 6(3):323-32. PubMed ID: 9778651
[TBL] [Abstract][Full Text] [Related]
28. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
29. [3H]-beta-endorphin binding in rat brain.
Houghten RA; Johnson N; Pasternak GW
J Neurosci; 1984 Oct; 4(10):2460-5. PubMed ID: 6092561
[TBL] [Abstract][Full Text] [Related]
30. [Interaction of ethanol with opiate receptors].
Iukhananov RIu; Maĭskiĭ AI; Burov IuV
Biull Eksp Biol Med; 1985 Nov; 100(11):588-91. PubMed ID: 2998507
[TBL] [Abstract][Full Text] [Related]
31. Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanisms.
Danks JA; Tortella FC; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW; Rothman RB
Neuropharmacology; 1988 Sep; 27(9):965-74. PubMed ID: 2847072
[TBL] [Abstract][Full Text] [Related]
32. Microtubule disassembly increases the number of opioid receptor binding sites in rat cerebrum membranes.
Borsodi A; Toth G
Neuropeptides; 1986 Jul; 8(1):51-4. PubMed ID: 3020468
[TBL] [Abstract][Full Text] [Related]
33. Opiate binding sites and endogenous opioids in Bufo viridis oocytes.
Bakalkin GYa ; Yakovleva TV; Nikitina LA; Korobov NV; Vinogradov VA; Titov MI
Biochem Biophys Res Commun; 1983 Dec; 117(3):718-24. PubMed ID: 6320813
[TBL] [Abstract][Full Text] [Related]
34. Effects of phospholipases C from bacteria on binding of enkephalin to rat brain membranes.
Nakajima M; Taguchi R; Ikezawa H
Toxicon; 1987; 25(5):555-64. PubMed ID: 3039692
[TBL] [Abstract][Full Text] [Related]
35. Buprenorphine: high-affinity binding to dorsal spinal cord.
Villiger JW; Taylor KM
J Neurochem; 1982 Jun; 38(6):1771-3. PubMed ID: 6281389
[TBL] [Abstract][Full Text] [Related]
36. Photoaffinity crosslinking of etorphine with opioid binding sites in the bovine adrenal medulla.
Cantau P; Bourhim N; Giraud P; Oliver C; Castanas E
Biotechnol Appl Biochem; 1987 Apr; 9(2):114-22. PubMed ID: 3036179
[TBL] [Abstract][Full Text] [Related]
37. Naloxonazine actions in vivo.
Ling GS; Simantov R; Clark JA; Pasternak GW
Eur J Pharmacol; 1986 Sep; 129(1-2):33-8. PubMed ID: 3021478
[TBL] [Abstract][Full Text] [Related]
38. The effect of pH on stereospecific opiate binding to mouse brain membranes.
Smith AP
Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):375-98. PubMed ID: 19822
[TBL] [Abstract][Full Text] [Related]
39. Repeated electroconvulsive shock: effect on sodium dependency and regional distribution of opioid-binding sites.
Hitzemann RJ; Hitzemann BA; Blatt S; Meyerhoff JL; Tortella FC; Kenner JR; Belenky GL; Holaday JW
Mol Pharmacol; 1987 May; 31(5):562-6. PubMed ID: 3033470
[TBL] [Abstract][Full Text] [Related]
40. Naloxonazine, a potent, long-lasting inhibitor of opiate binding sites.
Hahn EF; Pasternak GW
Life Sci; 1982 Sep 20-27; 31(12-13):1385-8. PubMed ID: 6292633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
